Rapamycin decelerates cellular senescence

被引:330
作者
Demidenko, Zoya N. [1 ]
Zubova, Svetlana G. [2 ]
Bukreeva, Elena I. [2 ]
Pospelov, Valery A. [2 ]
Pospelova, Tatiana V. [2 ]
Blagosklonny, Mikhail V. [1 ,3 ]
机构
[1] Oncotarget, Albany, NY USA
[2] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia
[3] Ordway Res Inst, Albany, NY USA
基金
俄罗斯基础研究基金会;
关键词
cellular senescence; cell cycle arrest; aging; rapamycin; mTOR; TOR; MAMMALIAN TARGET; LIFE-SPAN; ARREST; CELLS; GROWTH; TOR; YEAST; LEADS; P53;
D O I
10.4161/cc.8.12.8606
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
When the cell cycle is arrested but cellular growth is not, then cells senesce, permanently losing proliferative potential. Here we demonstrated that the duration of cell cycle arrest determines a progressive loss of proliferative capacity. In human and rodent cell lines, rapamycin (an inhibitor of mTOR) dramatically decelerated loss of proliferative potential caused by ectopic p21, p16 and sodium butyrate-induced p21. Thus, when the cell cycle was arrested by these factors in the presence of rapamycin, cells retained the capacity to resume proliferation, once p21, p16 or sodium butyrate were removed. While rapamycin prevented the permanent loss of proliferative potential in arrested cells, it did not force the arrested cells into proliferation. During cell cycle arrest, rapamycin transformed the irreversible arrest into a reversible condition. Our data demonstrate that senescence can be pharmacologically suppressed.
引用
收藏
页码:1888 / 1895
页数:8
相关论文
共 17 条
[1]   G1/S arrest induced by histone deacetylase inhibitor sodium butyrate in E1A+Ras-transformed cells is mediated through down-regulation of E2F activity and stabilization of β-catenin [J].
Abramova, Maria V. ;
Pospelova, Tatiana V. ;
Nikulenkov, Fedor P. ;
Hollander, Christine M. ;
Fornace, Albert J., Jr. ;
Pospelov, Valery A. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (30) :21040-21051
[2]   Aging, stem cells, and mammalian target of rapamycin: A prospect of pharmacologic rejuvenation of aging stem cells [J].
Blagosklonny, Mikhail V. .
REJUVENATION RESEARCH, 2008, 11 (04) :801-808
[3]   An anti-aging drug today: from senescence-promoting genes to anti-aging pill [J].
Blagosklonny, Mikhail V. .
DRUG DISCOVERY TODAY, 2007, 12 (5-6) :218-224
[4]   Aging and immortality - Quasi-programmed senescence and its pharmacologic inhibition [J].
Blagosklonny, Mikhail V. .
CELL CYCLE, 2006, 5 (18) :2087-2102
[5]   Cell senescence and hypermitogenic arrest [J].
Blagosklonny, MV .
EMBO REPORTS, 2003, 4 (04) :358-362
[6]  
BLAGOSKLONNY MV, 2006, J CELL PHYSL
[7]   Cellular senescence: when bad things happen to good cells [J].
Campisi, Judith ;
di Fagagna, Fabrizio d'Adda .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (09) :729-740
[8]  
Chang BD, 1999, CANCER RES, V59, P3761
[9]   p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells [J].
Chang, BD ;
Broude, EV ;
Fang, J ;
Kalinichenko, TV ;
Abdryashitov, R ;
Poole, JC ;
Roninson, IB .
ONCOGENE, 2000, 19 (17) :2165-2170
[10]   Growth stimulation leads to cellular senescence when the cell cycle is blocked [J].
Demidenko, Zoya N. ;
Blagosklonny, Mikhail V. .
CELL CYCLE, 2008, 7 (21) :3355-3361